Journal Papers 799 Related Insights 0
Novel SLC10A2 variants induce primary bile acid malabsorption and dysbiosis with IBD-like features Casey R Johnson, MD; Lily Gillette, BS; Qurbonali Qurbonov, BS; Abigail Plone, BS; Stefanie S Schmieder, PhD; Michael Anderson, PhD; Katie Cibelli; Yanjia Jason Zhang, MD, PhD; Krishnan Raghunathan, PhD; Michael Field, MS; Alka Goyal, MD; Stacy A Kahn, MD; Scott B Snapper, MD, PhD; Jocelyn A Silvester, MD, PhD; Jay R Thiagarajah, MD, PhD; null Share Save
Healthcare professionals’ knowledge, attitudes, and practice with addressing sexual health among people living with inflammatory bowel disease: A UK cross-sectional survey Anish J Kuriakose Kuzhiyanjal, MD, MMed; Sarah Rhodes, MSc, PhD; Karishma Sethi-Arora, BSc, MRCP; Laura Hancock, FRCS; Christian Selinger, MD, MSc; Christopher A Lamb, MRes, PhD; David T Rubin, MD; Jimmy K Limdi, FRCP Share Save
Mast cell–derived IL-13 as a driver of Crohn disease–associated intestinal fibrosis Kwestan Safari, BSc; Wei Jen Ma, BSc; Prabhreet Sekhon, MSc; Priya Rai, BSc; Susan C Menzies; Tomoaki Hoshino, MD, PhD; Anne-Sophie Fratzscher, BSc; Andrew Roth, PhD; Karen Madsen, PhD; Laura M Sly, PhD Share Save
Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn’s disease David L Suskind, MD; Lucas R Hoffman, MD; Dale Lee, MD; Adrian J Verster, PhD; Hengqi Betty Zheng, MD; Kendra Francis, MD; Mason Nuding, BS; Jairam Vanamala, PhD; Ghassan Wahbeh, MD; Hayley Purcell, PhD; Danijel Djukovic, PhD; Daniel Raftery, PhD; Hillary S Hayden, PhD Share Save
Timing of biologic prophylaxis and postoperative recurrence in Crohn’s disease: A real-life cohort study using propensity score weighting Angelo Del Gaudio, MD; Federica Di Vincenzo, MD; Giuseppe Cuccia, MD; Gaetano Coppola, MD; Lucrezia Laterza, MD, PhD; Franco Sacchetti, MD; Paola Caprino, MD; Luigi Sofo, MD; Gabriele Dragoni, MD, PhD; Elisa Foscarini, LM-9; Francesca Profeta, LM-9; Elisa Schiavoni, RN, MSN; Daniele Napolitano, RN, MSN; Antonio Gasbarrini, MD, PhD; Daniela Pugliese, MD, PhD; Alfredo Papa, MD, PhD; Loris Riccardo Lopetuso, MD, PhD; Franco Scaldaferri, MD, PhD; null Share Save
Inflammatory bowel disease in the aging population Adam S Faye, MD, MS; Bharati Kochar, MD, MS; David Choi, PharmD; Thais Gift, PharmD; Kendra J Kamp, PhD, MS, RN; Nicholas L Rider, DO; Gilaad G Kaplan, MD, MPH; null Share Save
Anorectal fibrosis in 3 murine models of chronic intestinal fibrosis: a comparative analysis Yuanyuan Ge, MD, PhD; Meng Li, MD; Tianyi Li, MD; Dongliang Guo, MD; Miao Yu, MD; Jingjing Yue, MD; Xiangyu Liu, MD; Yan Liu, MD; Qiang Leng, MD; Kang Ding, MD, PhD Share Save
Patients with Crohn’s disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone Sudheer Kumar Vuyyuru, MD, DM; Shane W Goodwin, PhD; Virginia Solitano, MD; Darryl Ramsewak, MD; Zahra Kassam, MD; Cassandra Townsend, MD; Jamie Gregor, MD; Melanie Beaton, MD; Eileen Crowley, MD; Maan Alkhattabi, MD; Michael Sey, MD; Vipul Jairath, MBChB, DPhil Share Save
Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumab Joyce Lee, MD; Rachel Porth, MD; Alessandra Saraga, MD; Ajay Gade, MD; Tina Deyhim, MD; Mostafa Soliman, MD; Sadra Habibi Moini, MD; Samantha Zullow, MD; Loren Rabinowitz, MD; Laurie Grossberg, MD; Adam S Cheifetz, MD; Konstantinos Papamichael, MD, PhD Share Save
Association of preoperative neoplasia and rectal cuff inflammation on initial pouchoscopy with subsequent neoplasia development in inflammatory bowel disease patients with an ileal pouch-anal anastomosis: a case-control study Joseph Carter Powers, MD, MS; Mark Zemanek, DO; Mili Dave, BA; Emma Dester, MS; Katherine Westbrook Cates, DO; Riley Smith, DO; Tracy Hull, MD; Olga Lavryk, MD; Benjamin L Cohen, MD, MAS; Bret Lashner, MD, MPH; Andrei I Ivanov, PhD; Edward Barnes, MD, MPH; Katherine Falloon, MD; Manuel Braga-Neto, MD, PhD; Taha Qazi, MD Share Save
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease Mahmud Hussain, PhD; Anne Y Lai, PhD; Derek Franklin, PhD; Karen Lenz, BS; Arpita Patel, BSc; Noah Murr, MS; Harunobu Kato, BA; Lini Pandite, MD; Taylor H Schreiber, MD, PhD; Suresh de Silva, PhD Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}